Thecell sorting marketis witnessing strong growth, valued atUSD 269.16 Million in 2024and projected to rise fromUSD 288.08 Million in 2025toUSD 496.09 Million by 2033, at a CAGR of7.03%. This momentum is being driven by breakthroughs in precision medicine, automation, and the rising demand for advanced diagnostic technologies across research and clinical settings.
Cell sorting is vital for isolating target cells from mixed populations, enabling breakthroughs in cancer immunology, stem cell research, drug discovery, and diagnostics. With automation and AI-based platforms boosting speed and accuracy, researchers and clinicians are increasingly adopting these solutions for personalized medicine and biopharmaceutical manufacturing.
Key Market Insights
Technological Advancements: AI-powered platforms, image-activated cell sorting (IACS), and microfluidics are reshaping single-cell analysis.
Chronic Disease Impact: Nearly 42% of 129 million Americans live with multiple chronic conditions, underlining the need for precision-driven therapies supported by advanced cell sorting.
Regional Leadership: North America dominates the market, while Asia-Pacific is expected to grow at the fastest pace thanks to strong government support, cancer research, and expanding pharmaceutical sectors.
Market Trends
Rising adoption ofhigh-throughput automated systemsusing AI, robotics, and microfluidics.
Surge inMEMS-based chip sorters, such as Highway1, processing up to 43,000 cells per second.
Expanding use ofsingle-cell analysisin oncology and immunotherapy.
Growth Drivers
Strong government and privatefundingin next-gen sorting technologies (e.g., ThinkCytes USD 32 million Series C funding in 2024).
Rising need forbiopharma manufacturingand regenerative medicine.
Growing importance ofprecision medicinein cancer care and immunotherapy.
Market Challenges
High cost of advanced systems such asBD FACSAria IIIandSony SH800S.
Ongoing expenses from fluorophores, reagents, and service contracts, limiting adoption in smaller labs and emerging markets.
Opportunities
Expansion ofsingle-cell analysisin cancer and regenerative medicine.
Breakthroughs inlab-on-chip acoustofluidic systemsfor real-time cancer diagnostics.
Increasing adoption ofAI-driven sortingfor precision-based therapies.
Regional Highlights
U.S.: Expected 2,001,140 new cancer cases in 2024, fueling demand for high-precision sorting.
China: Advancing withRaman-activated platformsachieving 95% genome coverage.
India: Strong government RD support driving cancer and drug discovery research.
Japan: Sysmex launched automated flow cytometry systems, pushing clinical diagnostics forward.
Germany: Introduced the first commercialFACS servicefor biopharma in 2025.
Product Technology Insights
Cell sortersdominate the product segment due to their pivotal role in high-throughput single-cell analysis.
Fluorescence-based droplet sortingleads in technology, enabling precision and speed in oncology and immunology research.
Key Players
BD
Bio-Rad Laboratories, Inc.
Danaher
Sony Biotechnology Inc
Miltenyi Biotec
Thermo Fisher Scientific Inc.
Beckman Coulter, Inc.
Deepcell, Inc.
Sysmex Europe SE
STEMCELL Technologies
Terumo BCT, Inc.
On-chip Biotechnologies Co., Ltd.
Union Biometrica, Inc.
Bay Biosciences LLC
uFluidix
Notable Development:In April 2024,BDlaunched theFACSDiscover S8 Cell Sorter, integrating spectral flow cytometry with real-time imaging, setting a new standard for accuracy and speed.
Analyst View
The cell sorting market is entering a transformative phase. While high costs remain a restraint, demand is surging across oncology, immunotherapy, and regenerative medicine. Emerging economies in Asia-Pacific, backed by government initiatives and biotech growth, are expected to create substantial opportunities. The integration of AI and automation is not just enhancing efficiency but redefining the future of biomedical research and patient care.
About Us:
Straits Research is a leading global market intelligence and consulting firm, dedicated to delivering actionable insights and in-depth analysis across a wide range of industries. Our mission is to empower organizations, investors, and decision-makers with reliable data, strategic guidance, and forward-looking perspectives to help them thrive in a rapidly evolving business landscape.
Contact Us:
Email:sales@straitsresearch.com
Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)
Website:https://straitsresearch.com/
